Sesen Bio, Inc. announced an increase of the one-time special cash dividend expected to be paid to stockholders to $75.0 million, or approximately $0.36 per share. This represents an increase from the expected special cash dividend of approximately $70.0 million, or approximately $0.34 per share1, under the first amendment to the merger agreement, and an increase from the up to $25.0 million special cash dividend under the terms of the original merger agreement dated September 20, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.03 USD | 0.00% |
|
-16.94% | -64.85% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.85% | 42.79M | |
+14.84% | 121B | |
+18.31% | 112B | |
+1.86% | 22.72B | |
-18.26% | 20.82B | |
-41.55% | 16.36B | |
-14.23% | 16.19B | |
-18.12% | 16.66B | |
-0.68% | 13.17B | |
+21.87% | 11.11B |
- Stock Market
- Equities
- CARM Stock
- News Carisma Therapeutics, Inc.
- Sesen Bio, Inc. Announces Increase of One-Time Special Cash Dividend